Joseph Ezra Panoff, MD

Adeel Kaiser, M.D., is a board-certified radiation oncologist at Baptist Health Miami Cancer Institute and clinical associate professor at Florida International University Herbert Wertheim College of Medicine. He specializes in the treatment of gastrointestinal and genitourinary cancers using proton beam, IMRT, and theranostic and MRI-guided adaptive therapies. He aims to provide each patient with a personalized, integrative treatment strategy for their cancer by incorporating complementary therapies with state-of-the-art radiation technology. Dr. Kaiser attained his undergraduate and medical degrees from Johns Hopkins University and completed his radiation oncology training at the University of California Irvine/City of Hope Integrated Program in Radiation Oncology. Prior to joining Miami Cancer Institute, he held faculty appointments at the University of Maryland, Johns Hopkins University and Loma Linda University. At the University of Maryland, he served as director of the Advanced Modalities Fellowship Program. This program trained national and international students in emerging radiation oncology modalities, including pencil beam proton therapy, GammaPod radiosurgery and deep tissue hyperthermia. Dr. Kaiser also served as instructor of the Varian Proton Therapy School as well as director of the Integrative Wellness Program at the Maryland Proton Treatment Center, which sought to incorporate diet, exercise, acupuncture and emotional support strategies with radiation therapy. Dr. Kaiser is widely published in peer-reviewed medical journals. He has led multiple clinical trials and was the first radiation oncologist to lead an NIH-funded ketogenic diet pilot study for patients undergoing active surveillance for prostate cancer. Dr. Kaiser is fluent in English, Urdu and Hindi.

Minesh Mehta, M.D., is a renowned expert in radiation oncology, proton therapy and cancer research and serves as deputy director and the John and Mary Lou Dasburg Endowed Chair in Radiation Oncology at Baptist Health Miami Cancer Institute, chief of Radiation Oncology at Baptist Health, and chair of the Department of Oncological Sciences at Florida International University Herbert Wertheim College of Medicine. Dr. Mehta received his medical degree with highest honors from the University of Zambia School of Medicine. He completed a residency at the University of Wisconsin, where he was later appointed chairman of the medical school’s Department of Human Oncology. As part of his leadership efforts, Dr. Mehta directed research studies, technology development and the expansion at the University of Wisconsin Cancer Center. He also directed its brain tumor program for more than 15 years, leading to his national leadership role in clinical trial research. Dr. Mehta has designed and led numerous national and international clinical studies, receiving National Institutes of Health and National Cancer Institute grants and winning honors for his research in brain and central nervous system tumors. He helped launch and was the medical director of the Maryland Proton Treatment Center in Baltimore, prior to joining Baptist Health. Dr. Mehta is board certified in radiation oncology by the American Board of Radiology and in neuro-oncology by the United Council for Neurologic Subspecialties. He has held national leadership positions in numerous organizations, including the American Board of Radiology, the FDA Radiological Devices Panel, the American Society for Radiation Oncology, the American Society of Clinical Oncology and the Society of Neuro-Oncology. An avid researcher, Dr. Mehta provides a multidisciplinary, innovative approach to individual care and helps all his patients understand their diagnosis, available treatment options and potential clinical trials

Maria-Amelia Rodrigues, M.D., is a radiation oncologist at Miami Cancer Institute, a part of Baptist Health South Florida. She received her medical degree from the University of Rio de Janeiro School of Medicine in Brazil and completed an internship in internal medicine at Hospital de Clinicas Gaffree Guinle, University of Rio de Janeiro, and the Kaiser Foundation Medical Center, San Francisco. She also completed a residency in radiation oncology at the University of California – San Francisco, and a fellowship in hematology/oncology at Instituto Nacional de Cancer in Rio de Janiero. In addition, she was visiting fellow in the department of hematology/oncology at the University of Tennessee in Memphis. Dr. Rodrigues is Board-certified in radiation oncology.